Global Infection Control Devices Market is valued at USD 53.57 Billion in 2022 and it is expected to reach USD 75.13 Billion by 2029 with a CAGR of 4.95% over the forecast period.
Global Infection Control Devices Market: Global Size, Trends, Competitive, and Historical & Forecast Analysis, 2022-2029: The market will expand due to the increasing prevalence of infectious diseases, growing awareness of the importance of infection control, and technological advancements in infection control devices.
Infection control devices are medical devices designed to prevent or reduce the transmission of infectious agents in healthcare settings. These devices play a critical role in preventing healthcare-associated infections (HAIs) and protecting healthcare workers, patients, and visitors from the spread of infectious diseases. The use of infection control devices can be traced back to the early 20th century when healthcare professionals started to recognize the importance of hand hygiene and the need to prevent the spread of infectious diseases. Over the years, the development of new technologies and the adoption of evidence-based guidelines have led to the creation of various infection control devices.
Infection control devices are used in a wide range of healthcare settings, including hospitals, clinics, ambulatory surgery centers, long-term care facilities, and home healthcare. Some examples of infection control devices include hand hygiene products, personal protective equipment (PPE), disinfection and sterilization equipment, sharps disposal containers, and surface cleaning products.
The end-users of infection control devices include healthcare providers, patients, and visitors. Healthcare providers such as doctors, nurses, and other support staff use these devices to protect themselves and their patients from the spread of infectious diseases. Patients and visitors can also benefit from infection control devices by reducing their risk of acquiring an infection while receiving care.
COVID-19 has had a significant impact on the infection control device market, both positive and negative. The COVID-19 pandemic has increased the demand for infection control devices, including hand sanitizers, disinfectants, masks, and other personal protective equipment (PPE). This has led to an increase in sales and revenue for manufacturers of these products. Additionally, the pandemic has increased awareness of the importance of infection control in healthcare settings, which may lead to more investment in research and development of infection control devices in the future.
The COVID-19 pandemic has also had a negative impact on the supply chain for infection control devices. Due to disruptions in the global supply chain, some manufacturers have experienced delays or shortages in the raw materials and components needed to produce their products. Additionally, some manufacturers have faced increased competition and price pressure due to the high demand for infection control devices.
As of February 20, 2023, there have been over 453 million confirmed cases of COVID-19 worldwide, with over 6.1 million deaths, according to the World Health Organization. The United States has had the highest number of confirmed cases and deaths, with over 101 million confirmed cases and over 1.9 million deaths. However, the number of reported cases and deaths may not reflect the true impact of the pandemic, as some cases may go unreported or undetected.
Some major key players for the global Infection Control Devices Market report cover prominent players like -
The revenue generation model for infection control devices varies depending on the type of device and the market segment. Some manufacturers sell their devices directly to healthcare providers, while others may use distributors or third-party sellers to reach their target customers. The pricing of infection control devices may be influenced by factors such as competition, market demand, and regulatory requirements.
The supply chain model for infection control devices typically involves manufacturers, distributors, and end-users. Manufacturers produce the devices and may use distributors or third-party sellers to distribute them to their target customers. End-users such as hospitals or clinics may purchase these devices directly from the manufacturer or through a distributor.
The value chain model for infection control devices includes various stages, including product design, manufacturing, distribution, marketing, and post-sales support. Each stage of the value chain contributes to the overall value of the device, and manufacturers need to ensure that each stage is optimized to deliver the best possible product to the end-user. The value chain model is essential to ensure that infection control devices are effective, efficient, and affordable for healthcare providers and patients.
Increasing prevalence of infectious diseases: The increasing prevalence of infectious diseases such as COVID-19, tuberculosis, and hospital-acquired infections (HAIs) is driving the demand for infection control devices. According to the World Health Organization (WHO), approximately 1.7 million people die from HAIs every year, making it a major public health concern.
For example, the World Health Organization (WHO) estimates that there are globally 300–500 million cases of malaria, 333 million cases of sexually transmitted diseases (syphilis, gonorrhea, chlamydia, and trichomonas), 33 million cases of HIV/AIDS, 14 million people infected with tuberculosis, and 3–5 million cases of cholera each year.
Growing awareness of the importance of infection control: The growing awareness of the importance of infection control in healthcare settings is driving the demand for infection control devices. Healthcare providers are increasingly emphasizing the importance of infection prevention to reduce the risk of HAIs.
For example, According to a survey by Harris Poll conducted in April 2020, 87% of Americans believed it was very important for healthcare providers to use infection control measures such as hand hygiene and wearing personal protective equipment to prevent the spread of COVID-19.
In a survey of 1,500 adults conducted in May 2020 by Infection Control Today magazine, 78% of respondents reported that they had become more aware of the importance of infection control in the wake of the COVID-19 pandemic.
Lack of awareness and education: The lack of awareness and education about the importance of infection control in healthcare settings is a major restraining factor for the market. Healthcare providers and patients may not be aware of the risks of HAIs and the importance of infection prevention measures. For example, a study published in the New England Journal of Medicine found that in the United States, approximately 1.7 million HAIs occur each year, resulting in approximately 99,000 deaths and up to $45 billion in additional healthcare costs.
Stringent regulatory requirements: Stringent regulatory requirements for infection control devices can be a barrier to entry for new market players. Obtaining regulatory approval for these devices can be a lengthy and expensive process. For example, In the United States, the Food and Drug Administration (FDA) regulates infection control devices and requires manufacturers to obtain FDA clearance or approval before marketing their products. This process can be time-consuming and expensive, as manufacturers must provide data to demonstrate the safety and effectiveness of their products.
Additionally, the US Government Accountability Office (GAO) found that the FDA's premarket review process for medical devices, which includes infection control devices, can take an average of 177 days for a 510(k) clearance and 365 days for premarket approval (PMA).
Growing prevalence of chronic diseases: The growing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases, is increasing the demand for infection control devices, as patients with chronic diseases are more susceptible to infections. For example, According to the World Health Organization (WHO), chronic diseases are the leading cause of death worldwide, accounting for 71% of all deaths.
Increasing demand for single-use devices: The demand for single-use infection control devices is on the rise, as they provide a cost-effective and convenient way to reduce the risk of infections. Approximately 20 to 30% of U.S. hospitals reported that they reuse at least one type of single-use device.
Product and technology development: There has been a growing trend towards the development of innovative infection control devices, including those that use advanced technologies such as ultraviolet (UV) light, hydrogen peroxide vapor, and electrostatic sprayers to disinfect surfaces and equipment. There is also a trend toward the development of more portable and user-friendly devices, such as handheld disinfection devices and disinfection robots.
Customer trends: Customers are increasingly looking for infection control devices that are effective, easy to use, and affordable. There is a growing trend towards the adoption of single-use devices, which are designed to be used once and then discarded, reducing the risk of infection transmission. Customers are also looking for devices that are environmentally friendly and do not contribute to pollution or waste.
Competition in the market: The Infection Control Devices Market is highly competitive, with a large number of global and regional players. The key players in the market are focused on product innovation, strategic partnerships, and mergers and acquisitions to gain a competitive edge. The market is also characterized by the presence of many smaller players offering low-cost products, creating price competition.
Strategies adopted by key market players: Key market players have adopted various strategies to maintain their position in the market. For example, some companies have focused on developing new products and technologies to meet customer needs, while others have focused on expanding their global presence through partnerships and acquisitions. Some companies have also focused on providing training and support to healthcare providers to ensure the proper use of their products. In the future, key market players are likely to continue focusing on innovation, cost-effective products, and strategic partnerships to stay ahead of the competition.
North America is a major market for infection control devices, driven by the increasing prevalence of HAIs, the growing demand for single-use devices, and the presence of leading market players. In addition, the high awareness among healthcare providers and patients about the importance of infection control is also driving the market growth.
According to the Centers for Disease Control and Prevention (CDC), in the United States alone, there are an estimated 1.7 million HAIs each year, leading to around 99,000 deaths. The high incidence of HAIs in healthcare facilities has led to a greater focus on infection control measures and the use of infection control devices to prevent the spread of infections.
Europe is a significant market for infection control devices, driven by the increasing focus on patient safety and the high prevalence of HAIs. The growing adoption of advanced technologies and the development of innovative infection control devices are also driving the market growth. For example, The European Centre for Disease Prevention and Control (ECDC) estimates that approximately 4.1 million patients are affected by HAIs in the European Union each year. The increasing prevalence of HAIs in Europe is estimated to cost around €7 billion annually, according to the European Parliament.